Medicare can cover weight loss drugs if used for added health benefit

Medicare can cover weight loss drugs if used for added health benefit

Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024.  Hollie Adams | Reuters Medicare can start covering certain weight loss drugs for the first time – as long as they are approved for an added health benefit, the Centers for Medicare and Medicaid Services said Thursday. … Read more

First NASH liver disease drug is here, more coming

First NASH liver disease drug is here, more coming

3D Illustration of a human liver organ. magicmine | iStock | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! Millions of Americans with a common and potentially life-threatening form of liver disease will soon have access to the first-ever treatment for … Read more

Wegovy heart health approval won’t mean broad insurance coverage yet

Wegovy heart health approval won’t mean broad insurance coverage yet

Victoria Klesty | Reuters In the U.S., Wegovy is no longer just for weight loss. The blockbuster drug — one of a handful of weight loss treatments to skyrocket in popularity over the last year — is now approved in the U.S. for heart health, too. But that may not translate to wider insurance coverage of … Read more

Wegovy heart health approval won’t mean broad insurance coverage yet

Wegovy heart health approval won’t mean broad insurance coverage yet

Victoria Klesty | Reuters In the U.S., Wegovy is no longer just for weight loss. The blockbuster drug — one of a handful of weight loss treatments to skyrocket in popularity over the last year — is now approved in the U.S. for heart health, too. But that may not translate to wider insurance coverage of … Read more

WeightWatchers CEO just sent a memo to employees as stock crashes

WeightWatchers CEO just sent a memo to employees as stock crashes

Sima Sistani, CEO, WW International, August 16, 2023. Scott Mlyn | CNBC WeightWatchers CEO Sima Sistani has sent an internal memo to employees attempting to reassure them that the financial position of the company is solid and its new clinical business related to the threat of GLP-1 weight loss drugs is growing faster than expected. … Read more

FDA approves NASH liver disease drug from Madrigal Pharmaceuticals

FDA approves NASH liver disease drug from Madrigal Pharmaceuticals

In this photo illustration, the Madrigal Pharmaceuticals logo is displayed on a smartphone screen.  Rafael Henrique | SOPA Images | Lightrocket | Getty Images The Food and Drug Administration on Thursday approved the first-ever treatment for a common and potentially deadly form of liver disease that affects millions worldwide. The FDA’s decision means Madrigal Pharmaceuticals … Read more

Weight loss ETFs may sit out obesity drug mania, experts say

Weight loss ETFs may sit out obesity drug mania, experts say

There may be a stronger case to invest in single stocks over exchange-traded funds in the weight loss space. Amplify ETFs and Roundhill Investments each filed a prospectus last week to launch funds focused on weight loss companies, a move that Strategas ETF and technical strategist Todd Sohn believes hinges on the performance of two … Read more

Eli Lilly taps Amazon Pharmacy to help deliver Zepbound, other drugs

Eli Lilly taps Amazon Pharmacy to help deliver Zepbound, other drugs

Close-up of a hand holding a cellphone displaying the Amazon Pharmacy system, Lafayette, California, September 15, 2021.  Smith Collection | Gado | Getty Images Eli Lilly on Wednesday said Amazon Pharmacy will help send certain prescription drugs, including the red-hot weight loss treatment Zepbound, to patients’ homes through the drugmaker’s new direct-to-consumer program.  Starting Wednesday, … Read more

Novo Nordisk’s Wegovy wins FDA approval for heart health benefits

Novo Nordisk’s Wegovy wins FDA approval for heart health benefits

Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21, 2023. Victoria Klesty | Reuters The Food and Drug Administration approved Novo Nordisk‘s blockbuster weight loss drug Wegovy for use in slashing the risk of serious cardiovascular complications in people with obesity and heart disease, the … Read more

Weight loss pill could become a best-in-class drug

Weight loss pill could become a best-in-class drug

Novo Nordisk CEO Lars Fruergaard Jørgensen on Friday said the company’s experimental weight loss pill, amycretin, could eventually become a best-in-class treatment for obesity.  The Danish drugmaker is racing to capitalize on the runaway success of its blockbuster weight loss drug Wegovy by developing a new generation of treatments for obesity, including more convenient and … Read more